Jenette Creaney

Jenette Creaney

UNVERIFIED PROFILE

Are you Jenette Creaney?   Register this Author

Register author
Jenette Creaney

Jenette Creaney

Publications by authors named "Jenette Creaney"

Are you Jenette Creaney?   Register this Author

75Publications

1836Reads

8Profile Views

Advances in pathological diagnosis of mesothelioma: what pulmonologists should know.

Curr Opin Pulm Med 2019 Jul;25(4):354-361

Department of Respiratory Medicine, Sir Charles Gairdner Hospital.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MCP.0000000000000578DOI Listing
July 2019

MicroRNA Signatures in Malignant Pleural Mesothelioma Effusions.

Dis Markers 2019 31;2019:8628612. Epub 2019 Jul 31.

Institute for Respiratory Health and Centre for Respiratory Health, School of Biomedical Sciences, University of Western Australia, Nedlands, WA 6009, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2019/8628612DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6701424PMC
July 2019

Immunotherapy strategies for mesothelioma - the role of tumor specific neoantigens in a new era of precision medicine.

Expert Rev Respir Med 2019 02 30;13(2):181-192. Epub 2018 Dec 30.

b National Centre for Asbestos Related Disease , University of Western Australia , Nedlands , Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17476348.2019.1563488DOI Listing
February 2019

Tumour associated lymphocytes in the pleural effusions of patients with mesothelioma express high levels of inhibitory receptors.

BMC Res Notes 2018 Dec 5;11(1):864. Epub 2018 Dec 5.

National Centre for Asbestos Related Diseases, School of Medicine and Pharmacology, University of Western Australia, Nedlands, Western Australia, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13104-018-3953-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282254PMC
December 2018

Autoimmune antibodies and asbestos exposure: Evidence from Wittenoom, Western Australia.

Am J Ind Med 2018 07 24;61(7):615-620. Epub 2018 May 24.

Department of Microbiology and Immunology, Montana State University, Bozeman, Montana.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajim.22863DOI Listing
July 2018

Malignant cells from pleural fluids in malignant mesothelioma patients reveal novel mutations.

Lung Cancer 2018 05 9;119:64-70. Epub 2018 Mar 9.

National Centre for Asbestos Related Disease, University of Western Australia, Nedlands, Western Australia, 6009, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2018.03.009DOI Listing
May 2018

Malignant Mesothelioma Biomarkers: From Discovery to Use in Clinical Practice for Diagnosis, Monitoring, Screening, and Treatment.

Chest 2017 07 19;152(1):143-149. Epub 2016 Dec 19.

National Centre for Asbestos Related Diseases, School of Medicine and Pharmacology, University of Western Australia, Nedlands, WA, Australia; Department of Respiratory Medicine, Nedlands, WA, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.chest.2016.12.004DOI Listing
July 2017

Whole exome sequencing of an asbestos-induced wild-type murine model of malignant mesothelioma.

BMC Cancer 2017 06 2;17(1):396. Epub 2017 Jun 2.

National Centre for Asbestos Related Disease, School of Medicine and Pharmacology, QEII Medical Centre, University of Western Australia, QQ Block, 6 Verdun Street, Nedlands, WA, 6009, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-017-3382-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455120PMC
June 2017

Immunotherapy for Lung Malignancies: From Gene Sequencing to Novel Therapies.

Chest 2017 Apr 18;151(4):891-897. Epub 2016 Oct 18.

National Centre of Asbestos Related Diseases, School of Medicine and Pharmacology, University of Western Australia; Perth, Western Australia, Australia; Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.chest.2016.10.007DOI Listing
April 2017

A Proteomic Analysis of the Malignant Mesothelioma Secretome Using iTRAQ.

Cancer Genomics Proteomics 2017 Mar-Apr;14(2):103-117

National Centre for Asbestos Related Diseases, School of Medicine and Pharmacology, University of Western Australia, Sir Charles Gairdner Hospital, Perth, Western Australia.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5369310PMC
http://dx.doi.org/10.21873/cgp.20023DOI Listing
April 2017

Transient Treg depletion enhances therapeutic anti-cancer vaccination.

Immun Inflamm Dis 2017 03 21;5(1):16-28. Epub 2016 Nov 21.

School of Medicine and PharmacologyUniversity of Western Australia, QEII Medical CentreNedlandsWestern AustraliaAustralia; National Research Centre for Asbestos Related DiseasesQEII Medical CentreNedlandsWestern AustraliaAustralia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/iid3.136DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5322183PMC
March 2017

Malignant pleural fluid from mesothelioma has potent biological activities.

Respirology 2017 01 25;22(1):192-199. Epub 2016 Aug 25.

Pleural Medicine Unit, Institute for Respiratory Health, Perth, Western Australia, Australia.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/resp.12874
Publisher Site
http://dx.doi.org/10.1111/resp.12874DOI Listing
January 2017

Immune response profiling of malignant pleural mesothelioma for diagnostic and prognostic biomarkers.

Biomarkers 2016 Sep 24;21(6):551-61. Epub 2016 Mar 24.

g National Centre for Asbestos Related Diseases, School of Medicine and Pharmacology, University of Western Australia , Perth , Western Australia , Australia ;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/1354750X.2016.1160429DOI Listing
September 2016

Secreted primary human malignant mesothelioma exosome signature reflects oncogenic cargo.

Sci Rep 2016 09 8;6:32643. Epub 2016 Sep 8.

Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Victoria 3086, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/srep32643DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5015102PMC
September 2016

Protocol of the Australasian Malignant Pleural Effusion-2 (AMPLE-2) trial: a multicentre randomised study of aggressive versus symptom-guided drainage via indwelling pleural catheters.

BMJ Open 2016 07 5;6(7):e011480. Epub 2016 Jul 5.

Department of Respiratory Medicine, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia Pleural Medicine Unit, Institute for Respiratory Health, Perth, Western Australia, Australia Centre for Respiratory Health, School of Medicine & Pharmacology, University of Western Australia, Perth, Western Australia, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bmjopen-2016-011480DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4947772PMC
July 2016

Diagnoses (Not Diagnosis) of Pleural Effusion. Time to Consider Concurrent Etiologies.

Ann Am Thorac Soc 2016 07;13(7):1003-4

3 Pleural Medicine Unit, Centre for Respiratory Health, School of Medicine and Pharmacology, University of Western Australia, Nedlands, Western Australia, Australia; and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1513/AnnalsATS.201604-320EDDOI Listing
July 2016

Longitudinal Measurement of Pleural Fluid Biochemistry and Cytokines in Malignant Pleural Effusions.

Chest 2016 06 18;149(6):1494-500. Epub 2016 Jan 18.

Department of Respiratory Medicine, Sir Charles Gairdner Hospital, University of Western Australia, Perth, Australia; School of Medicine and Pharmacology, University of Western Australia, Perth, Australia; Pleural Medicine Unit, Institute of Respiratory Health, University of Western Australia, Perth, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.chest.2016.01.001DOI Listing
June 2016

A Novel Clinical Prediction Model for Prognosis in Malignant Pleural Mesothelioma Using Decision Tree Analysis.

J Thorac Oncol 2016 Apr 8;11(4):573-82. Epub 2016 Jan 8.

School of Medicine and Pharmacology, University of Western Australia, Perth, Australia; National Centre for Asbestos Related Diseases, University of Western Australia, Perth, Australia; Department of Medical Oncology, Sir Charles Gairdner Hospital, Perth, Australia.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864160028
Publisher Site
http://dx.doi.org/10.1016/j.jtho.2015.12.108DOI Listing
April 2016

Erratum to: ENOX2-based early detection (ONCOblot) of asbestos-induced malignant mesothelioma 4-10 years in advance of clinical symptoms.

Clin Proteomics 2016 22;13. Epub 2016 Feb 22.

National Centre for Asbestos Related Disease, University of Western Australia, Perth, Australia ; School of Medicine and Pharmacology, University of Western Australia, Perth, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12014-016-9105-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4762167PMC
February 2016

ENOX2-based early detection (ONCOblot) of asbestos-induced malignant mesothelioma 4-10 years in advance of clinical symptoms.

Clin Proteomics 2016 22;13. Epub 2016 Jan 22.

National Centre for Asbestos Related Disease, University of Western Australia, Perth, Australia ; School of Medicine and Pharmacology, University of Western Australia, Perth, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12014-016-9103-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4724078PMC
January 2016

Consistent gene expression profiles in MexTAg transgenic mouse and wild type mouse asbestos-induced mesothelioma.

BMC Cancer 2015 Dec 18;15:983. Epub 2015 Dec 18.

National Centre for Asbestos Related Diseases, School of Medicine and Pharmacology, University of Western Australia, M503, Harry Perkins Institute for Medical Research, QQ Block, QEII Medical Centre, Nedlands, Perth, 6009, Western Australia, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-015-1953-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4683914PMC
December 2015

Pleural fluid mesothelin as an adjunct to the diagnosis of pleural malignant mesothelioma.

Dis Markers 2014 23;2014:413946. Epub 2014 Nov 23.

School of Medicine and Pharmacology, University of Western Australia, M503, 23 Stirling Highway, Crawley, Perth, WA 6009, Australia ; National Centre for Asbestos Related Diseases, University of Western Australia, Nedlands, WA 6009, Australia ; Department of Respiratory Medicine, Sir Charles Gairdner Hospital, Nedlands, WA 6009, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2014/413946DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4258360PMC
July 2015

Comparison of mesothelin and fibulin-3 in pleural fluid and serum as markers in malignant mesothelioma.

Curr Opin Pulm Med 2015 Jul;21(4):352-6

aSchool of Medicine and Pharmacology bNational Centre for Asbestos Related Diseases, University of Western Australia, Perth cDepartment of Respiratory Medicine, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MCP.0000000000000167DOI Listing
July 2015

Strong spontaneous tumor neoantigen responses induced by a natural human carcinogen.

Oncoimmunology 2015 Jul 11;4(7):e1011492. Epub 2015 May 11.

National Centre for Asbestos Related Diseases; School of Medicine and Pharmacology; University of Western Australia ; Nedlands, Australia ; Australian Mesothelioma Tumour Bank; Sir Charles Gairdner Hospital ; Nedlands, Australia ; Department of Respiratory Medicine; Sir Charles Gairdner Hospital ; Nedlands, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2015.1011492DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485777PMC
July 2015

Absence of germline mutations in BAP1 in sporadic cases of malignant mesothelioma.

Gene 2015 May 18;563(1):103-5. Epub 2015 Mar 18.

National Centre for Asbestos Related Disease, School of Medicine and Pharmacology, University of Western Australia, Nedlands, Western Australia 6009, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.gene.2015.03.031DOI Listing
May 2015

Author's response: Inconsistent results or inconsistent methods? A plea for standardisation of biomarker sampling in mesothelioma studies.

Thorax 2015 Apr 5;70(4):374-5. Epub 2014 Dec 5.

National Centre for Asbestos Related Diseases, School of Medicine and Pharmacology, University of Western Australia, Nedlands, Western Australia, Australia The Australian Mesothelioma Tissue Bank, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia Department of Respiratory Medicine, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/thoraxjnl-2014-206564DOI Listing
April 2015

Mitochondria-derived reactive oxygen species drive GANT61-induced mesothelioma cell apoptosis.

Oncotarget 2015 Jan;6(3):1519-30

Lung Institute of Western Australia and Centre for Asthma, Allergy and Respiratory Research, School of Medicine and Pharmacology, University of Western Australia, Harry Perkins Institute of Medical Research, Nedlands, WA, Australia.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359311PMC
http://dx.doi.org/10.18632/oncotarget.2729DOI Listing
January 2015

Discovery of new biomarkers for malignant mesothelioma.

Curr Pulmonol Rep 2015;4(1):15-21

National Centre for Asbestos Related Diseases, School of Medicine and Pharmacology, University of Western Australia, 35 Stirling Hwy, Crawley, 6009 Australia ; Australian Mesothelioma Tissue Bank, Sir Charles Gairdner Hospital, Verdun Ave, Nedlands, 6009 Western Australia Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13665-015-0106-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4356891PMC
January 2015

Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma.

Thorax 2014 Oct 18;69(10):895-902. Epub 2014 Jul 18.

National Centre for Asbestos Related Diseases, School of Medicine and Pharmacology, University of Western Australia, Nedlands, Western Australia, Australia The Australian Mesothelioma Tissue Bank, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia Department of Respiratory Medicine, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.

View Article

Download full-text PDF

Source
http://thorax.bmj.com/content/early/2014/07/18/thoraxjnl-201
Web Search
http://thorax.bmj.com/cgi/doi/10.1136/thoraxjnl-2014-205205
Publisher Site
http://dx.doi.org/10.1136/thoraxjnl-2014-205205DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4174124PMC
October 2014

Comparison of the diagnostic accuracy of the MSLN gene products, mesothelin and megakaryocyte potentiating factor, as biomarkers for mesothelioma in pleural effusions and serum.

Dis Markers 2013 6;35(2):119-27. Epub 2013 Aug 6.

National Centre for Asbestos Related Diseases, School of Medicine and Pharmacology, University of Western Australia and Australian Mesothelioma Tissue Bank, Sir Charles Gairdner Hospital, Perth, WA 6009, Australia.

View Article

Download full-text PDF

Source
http://www.hindawi.com/journals/dm/2013/874212/
Publisher Site
http://dx.doi.org/10.1155/2013/874212DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3774973PMC
June 2014

Bacterial infection elicits heat shock protein 72 release from pleural mesothelial cells.

PLoS One 2013 21;8(5):e63873. Epub 2013 May 21.

Pleural Disease Unit, Lung Institute of Western Australia, Centre for Asthma, Allergy and Respiratory Research, School of Medicine and Pharmacology, University of Western Australia, Perth, Western Australia.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0063873PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3660560PMC
December 2013

Pleural effusion hyaluronic acid as a prognostic marker in pleural malignant mesothelioma.

Lung Cancer 2013 Dec 9;82(3):491-8. Epub 2013 Oct 9.

National Centre for Asbestos Related Diseases, University of Western Australia, School of Medicine and Pharmacology, Nedlands, Western Australia, Australia; The Australian Mesothelioma Tissue Bank, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2013.09.016DOI Listing
December 2013

A genome-wide association study for malignant mesothelioma risk.

Lung Cancer 2013 Oct 1;82(1):1-8. Epub 2013 Jul 1.

Centre for Genetic Origins of Health and Disease, University of Western Australia, 35 Stirling Hwy, Crawley, Western Australia 6009, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2013.04.018DOI Listing
October 2013

A phase II clinical trial of the vascular disrupting agent BNC105P as second line chemotherapy for advanced Malignant Pleural Mesothelioma.

Lung Cancer 2013 Sep 17;81(3):422-427. Epub 2013 Jun 17.

NHMRC Clinical Trials Centre, University of Sydney, Medical Foundation Building, 92-94 Parramatta Road, Camperdown, NSW 2050, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2013.05.006DOI Listing
September 2013

The continual search for ideal biomarkers for mesothelioma: the hurdles.

J Thorac Dis 2013 Jun;5(3):364-6

Respiratory Medicine, Sir Charles Gairdner Hospital, Perth, Australia;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2072-1439.2013.04.19DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3698297PMC
June 2013

Does CA125 binding to mesothelin impact the detection of malignant mesothelioma?

Lung Cancer 2013 Apr 26;80(1):39-44. Epub 2013 Jan 26.

National Centre for Asbestos Related Diseases, School of Medicine and Pharmacology, University of Western Australia, Perth, Western Australia 6009, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2012.12.008DOI Listing
April 2013

Association of biomarker levels with severity of asbestos-related diseases.

Saf Health Work 2012 Mar 8;3(1):17-21. Epub 2012 Mar 8.

Department of Medical Humanities and Social Medicine, Kosin University College of Medicine, Busan, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5491/SHAW.2012.3.1.17DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3430922PMC
March 2012

Auto-antibodies to β-F1-ATPase and vimentin in malignant mesothelioma.

PLoS One 2011 17;6(10):e26515. Epub 2011 Oct 17.

National Centre for Asbestos Related Diseases, University of Western Australia, School of Medicine and Pharmacology, Nedlands, Western Australia, Australia.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0026515PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195718PMC
February 2012

Plasma versus serum levels of osteopontin and mesothelin in patients with malignant mesothelioma--which is best?

Lung Cancer 2011 Oct 12;74(1):55-60. Epub 2011 Mar 12.

National Research Centre for Asbestos Related Diseases, School of Medicine and Pharmacology, University of Western Australia, Sir Charles Gairdner Hospital, 4th Floor, G Block, Verdun St, Nedlands, WA 6009, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2011.02.007DOI Listing
October 2011

Mesothelin and kidney function--analysis of relationship and implications for mesothelioma screening.

Lung Cancer 2011 Sep 18;73(3):320-4. Epub 2011 Feb 18.

University of Western Australia, School of Medicine and Pharmacology, Verdun Street, Nedlands, WA 6009, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2011.01.011DOI Listing
September 2011

Mesothelial cells activate the plasma kallikrein-kinin system during pleural inflammation.

Biol Chem 2011 Jul 1;392(7):633-42. Epub 2011 Jun 1.

School of Biomedical, Biomolecular and Chemical Sciences, University of Western Australia, Perth.

View Article

Download full-text PDF

Source
https://www.degruyter.com/view/j/bchm.2011.392.issue-7/bc.20
Publisher Site
http://dx.doi.org/10.1515/BC.2011.062DOI Listing
July 2011

Serum soluble mesothelin concentrations in malignant pleural mesothelioma: relationship to tumor volume, clinical stage and changes in tumor burden.

Clin Cancer Res 2011 Mar 21;17(5):1181-9. Epub 2010 Dec 21.

National Research Centre for Asbestos Related Diseases, School of Medicine and Pharmacology, University of Western Australia, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-10-1929DOI Listing
March 2011

Serum mesothelin for early detection of asbestos-induced cancer malignant mesothelioma.

Cancer Epidemiol Biomarkers Prev 2010 Sep 22;19(9):2238-46. Epub 2010 Jul 22.

National Research Centre for Asbestos Related Disease, Sir Charles Gairdner Hospital, 2School of Medicine and Pharmacology, University of Western Australia, QEII Medical Centre, Nedlands, Western Australia, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-10-0346DOI Listing
September 2010

Sensitivity of urinary mesothelin in patients with malignant mesothelioma.

J Thorac Oncol 2010 Sep;5(9):1461-6

National Centre for Asbestos Related Diseases, Western Australian Institute of Medical Research, School of Medicine and Pharmacology, University of Western Australia, Sir Charles Gairdner Hospital, Nedlands, WA 6009, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/jto.0b013e3181e392d7DOI Listing
September 2010

Factors affecting soluble mesothelin related protein levels in an asbestos-exposed population.

Clin Chem Lab Med 2010 Jun;48(6):869-74

Department of Environmental Epidemiology, Institute of Industrial Ecological Sciences, University of Occupational and Environmental Health, Kitakyushu, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1515/CCLM.2010.165DOI Listing
June 2010

Serum and pleural fluid biomarkers for mesothelioma.

Curr Opin Pulm Med 2009 Jul;15(4):366-70

National Centre for Asbestos Related Diseases, Western Australian Institute of Medical Research, University of Western Australia, 4th Floor, G block, Sir Charles Gairdner Hospital, Verdun St, Nedlands, WA 6009, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MCP.0b013e32832b98ebDOI Listing
July 2009

Soluble mesothelin-related protein in an asbestos-exposed population: the dust diseases board cohort study.

Am J Respir Crit Care Med 2008 Oct 26;178(8):832-7. Epub 2008 Jun 26.

Research and Education Unit, Dust Disease Board, Level 2, 82 Elizabeth Street, Sydney, NSW 2000, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1164/rccm.200802-258OCDOI Listing
October 2008

Mesothelin-related predictive and prognostic factors in malignant mesothelioma: a nested case-control study.

Lung Cancer 2008 Aug 20;61(2):235-43. Epub 2008 Feb 20.

Department of Oncology, St. Olavs Hospital, Trondheim University Hospital, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2007.12.025DOI Listing
August 2008

Comparison of osteopontin, megakaryocyte potentiating factor, and mesothelin proteins as markers in the serum of patients with malignant mesothelioma.

J Thorac Oncol 2008 Aug;3(8):851-7

National Research Centre for Asbestos Related Diseases, Western Australian Institute of Medical Research, School of Medicine and Pharmacology, University of Western Australia, Sir Charles Gairdner Hospital, Nedlands, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e318180477bDOI Listing
August 2008

Combined CA125 and mesothelin levels for the diagnosis of malignant mesothelioma.

Chest 2007 Oct 23;132(4):1239-46. Epub 2007 Jul 23.

National Research Centre for Asbestos Related Diseases, 4th Floor, G Block, Sir Charles Gairdner Hospital, Verdun St, Nedlands, WA 6009, Australia.

View Article

Download full-text PDF

Source
http://journal.publications.chestnet.org/data/Journals/CHEST
Web Search
http://linkinghub.elsevier.com/retrieve/pii/S001236921536719
Publisher Site
http://dx.doi.org/10.1378/chest.07-0013DOI Listing
October 2007

Soluble mesothelin in effusions: a useful tool for the diagnosis of malignant mesothelioma.

Thorax 2007 Jul 13;62(7):569-76. Epub 2007 Mar 13.

Department of Medicine and Pharmacology, University of Western Australia, Sir Charles Gairdner Hospital, Verdun Ave, Nedlands 6009, Western Australia, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/thx.2006.068114DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2117248PMC
July 2007

A molecular diagnostic test for distinguishing lung adenocarcinoma from malignant mesothelioma using cells collected from pleural effusions.

Clin Cancer Res 2006 Sep;12(17):5129-35

Ian Potter Centre for Cancer Genomics and Predictive Medicine, Peter MacCallum Cancer Centre, East Melbourne, Australia.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-06-1027DOI Listing
September 2006

Recombinant GM-CSF plus autologous tumor cells as a vaccine for patients with mesothelioma.

Lung Cancer 2006 May 24;52(2):189-97. Epub 2006 Mar 24.

School of Medicine and Pharmacology, Sir Charles Gairdner Hospital Perth, Western Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2006.01.007DOI Listing
May 2006

Soluble mesothelin related protein in mesothelioma.

J Thorac Oncol 2006 Feb;1(2):172-4

School of Medicine and Pharmacology, University of Western Australia, Sir Charles Gairdner Hospital, Wedlands, WA, Australia.

View Article

Download full-text PDF

Source
February 2006

Detection of malignant mesothelioma in asbestos-exposed individuals: the potential role of soluble mesothelin-related protein.

Hematol Oncol Clin North Am 2005 Dec;19(6):1025-40, v

School of Medicine and Pharmacology, University of Western Australia, 4th Floor, G-Block, Sir Charles Gairdner Hospital, Nedlands 6009, Western Australia, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2005.09.007DOI Listing
December 2005

Soluble mesothelin-related protein--a blood test for mesothelioma.

Lung Cancer 2005 Jul;49 Suppl 1:S109-11

University Department of Medicine, University of Western Australia, Queen Elizabeth II Medical Centre, Perth, WA, Australia.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S016950020500103
Publisher Site
http://dx.doi.org/10.1016/j.lungcan.2005.03.020DOI Listing
July 2005

Mesothelin-family proteins and diagnosis of mesothelioma.

Lancet 2003 Nov;362(9396):1612-6

University Department of Medicine, University of Western Australia, Queen Elizabeth II Medical Centre, Western Australia, Perth, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(03)14794-0DOI Listing
November 2003

The BLM helicase is necessary for normal DNA double-strand break repair.

Cancer Res 2002 May;62(10):2766-70

Howard Hughes Medical Institute, Department of Molecular Genetics, Biochemistry, and Microbiology, The University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH 45267-0524, USA.

View Article

Download full-text PDF

Source
May 2002